Evidence map›Paper›PMID 31118576›Full record

ArticleDrug design, development and therapy2019

Synthesis of a vanadyl (IV) folate complex for the treatment of diabetes: spectroscopic, structural, and biological characterization.

Ahmed M Naglah, Moamen S Refat, Mohamed A Al-Omar, Mashooq A Bhat, Hamad M AlKahtani, Asma S Al-Wasidi

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ahmed M NaglahDepartment of Pharmaceutical Chemistry, Drug Exploration & Development Chair (DEDC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia, anaglah@ksu.edu.sa.
Moamen S RefatChemistry Department, Faculty of Science, Taif University, Taif 21974, Saudi Arabia.
Mohamed A Al-OmarDepartment of Pharmaceutical Chemistry, Drug Exploration & Development Chair (DEDC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia, anaglah@ksu.edu.sa.
Mashooq A BhatDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Hamad M AlKahtaniDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Asma S Al-WasidiDepartment of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
King Saud University · SAPrincess Nourah bint Abdulrahman University · SATaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to design a compound with folic acid (FAH MATERIALS AND

methodsA novel vanadyl (IV) FAH

resultsThe conductivity test of the complex implied electrolyte behavior. The spectroscopic assessments of the isolated dark yellow solid complex revealed that FAH

conclusionThe data generated in this study indicate that the synthesized vanadyl (IV) folate complex acts as a model of anti-diabetic agent.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalElectron Spin Resonance SpectroscopyFolic AcidHypoglycemic AgentsMaleMolecular StructureOrganometallic CompoundsParticle SizeRatsSpectrophotometry, InfraredStreptozocinSurface PropertiesThermodynamicsVanadatesFolic AcidHypoglycemic AgentsOrganometallic CompoundsStreptozocinVanadatesdiabetesfolic acidspectroscopicstreptozotocinvanadylvitamin B9

Identifiers

PMID31118576
PMCPMC6498434
OpenAlexW2943611993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.